NCT06982170

Brief Summary

Physical activity and reminiscence therapy alone have been studied with no clear effectiveness in Alzheimer's disease, but their combined intervention remains unknown. The health sector is now advocating the use of multiple interventions in dementia care. Here, we aim to develop a physical activity and reminiscence therapy device and investigate its effectiveness in older adults with dementia. As there is no existing device for the oldest old, who typically have frailty and comorbidities, we need to first design and co-design a novel device and conduct pilot studies for its feasibility, perception, sustained adoption (adherence) and then preliminary efficacy (usually pilot or phase I, and often single arm).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2023

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 15, 2025

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

May 13, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 21, 2025

Completed
Last Updated

May 21, 2025

Status Verified

May 1, 2025

Enrollment Period

1.1 years

First QC Date

May 13, 2025

Last Update Submit

May 13, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Cognitive ability (MoCA)

    MoCA is a measurement for cognitive ability. total score is 30 points, and higher score means better cognitive capacity, while lower score means higher possibie to be diagnosed as dementia.

    at the baseline, post-intervention assessment (e.g., after 12-week)

Secondary Outcomes (3)

  • physical ability

    at the baseline, post-intervention assessment (e.g., after 12-week)

  • psychology and behavior, caregiver distress

    at the baseline, post-intervention assessment (e.g., after 12-week)

  • depression

    at the baseline, post-intervention assessment (e.g., after 12-week)

Study Arms (1)

Interventional group

EXPERIMENTAL

participants who were recruited in this study, were

Device: A physical activity and reminiscence therapy

Interventions

There were two parts in this study, one was co-design (participants co-designed the device) and the other was a pilot intervention. The two parts were iterative. In the interventional part, participants were asked to cycling the co-design rehabilitation bike and also did reminiscence or any cognitive therapy at the same time. The intervention session lasted at least 15 minutes, twice a week for 12 weeks.

Interventional group

Eligibility Criteria

Age60 Years - 110 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • people who aged above 60
  • people who can pedal the usual rehabilitation bike
  • people who are willing to attend this study

You may not qualify if:

  • people who cannot cycle usual rehabilitation bike (assessed by care professionals)
  • people who cannot finish MoCA,

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hong Kong University of Science and Technology

Hong Kong, Hong Kong, Hong Kong

Location

MeSH Terms

Conditions

DementiaMotor Activity

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersMental DisordersBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DEVICE FEASIBILITY
Intervention Model
SINGLE GROUP
Model Details: This is a co-design and feasibility study for the device and a pilot interventional study to ensure the feasibility of a larger clinical trial intervention. So, the sample size would not be big as Phase I/II, and the interventional model is usually single arm, to test pre-post changes. But the screening and eligible criteria were totally same as any clinical trials.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 13, 2025

First Posted

May 21, 2025

Study Start

October 1, 2023

Primary Completion

October 30, 2024

Study Completion

April 15, 2025

Last Updated

May 21, 2025

Record last verified: 2025-05

Locations